Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥39.68 Million ≈ $5.81 Million USD) by net assets (CN¥4.23 Billion ≈ $618.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Xizang Haisco Pharmaceutical Group Co Lt worth for the company's overall valuation and market capitalisation.

Xizang Haisco Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Xizang Haisco Pharmaceutical Group Co Lt to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
SK TELECOM CO.LTD.ADR 5/9
F:KMBA
0.085x
LIG Nex1 Co Ltd
KO:079550
-0.343x
New York Times Company
NYSE:NYT
0.095x
Sociedad Química y Minera de Chile S.A.
SN:SQM-B
0.206x
The AES Corporation
NYSE:AES
0.128x
Nexchip Semiconductor Corp. A
SHG:688249
N/A
News Corp A
NASDAQ:NWSA
0.074x
Eurofins Scientific SE
PA:ERF
0.220x

Annual Cash Flow Conversion Efficiency for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. View Xizang Haisco Pharmaceutical Group Co Lt stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.29 Billion
≈ $627.44 Million
CN¥786.00 Million
≈ $115.02 Million
0.183x +74.26%
2024-12-31 CN¥4.20 Billion
≈ $614.92 Million
CN¥442.05 Million
≈ $64.69 Million
0.105x -2.42%
2023-12-31 CN¥4.17 Billion
≈ $610.28 Million
CN¥449.58 Million
≈ $65.79 Million
0.108x +257.25%
2022-12-31 CN¥3.13 Billion
≈ $458.49 Million
CN¥94.55 Million
≈ $13.84 Million
0.030x +146.13%
2021-12-31 CN¥2.92 Billion
≈ $427.32 Million
CN¥35.80 Million
≈ $5.24 Million
0.012x -83.03%
2020-12-31 CN¥2.85 Billion
≈ $417.74 Million
CN¥206.21 Million
≈ $30.17 Million
0.072x -77.54%
2019-12-31 CN¥2.38 Billion
≈ $347.78 Million
CN¥764.26 Million
≈ $111.84 Million
0.322x +35.70%
2018-12-31 CN¥1.99 Billion
≈ $291.83 Million
CN¥472.61 Million
≈ $69.16 Million
0.237x +19.17%
2017-12-31 CN¥1.97 Billion
≈ $288.32 Million
CN¥391.81 Million
≈ $57.33 Million
0.199x +9.11%
2016-12-31 CN¥2.25 Billion
≈ $328.53 Million
CN¥409.20 Million
≈ $59.88 Million
0.182x -11.28%
2015-12-31 CN¥2.16 Billion
≈ $315.58 Million
CN¥443.03 Million
≈ $64.83 Million
0.205x -13.86%
2014-12-31 CN¥2.11 Billion
≈ $308.37 Million
CN¥502.57 Million
≈ $73.54 Million
0.238x -19.15%
2013-12-31 CN¥1.93 Billion
≈ $281.97 Million
CN¥568.41 Million
≈ $83.18 Million
0.295x +8.40%
2012-12-31 CN¥1.71 Billion
≈ $249.91 Million
CN¥464.75 Million
≈ $68.01 Million
0.272x -19.89%
2011-12-31 CN¥767.76 Million
≈ $112.35 Million
CN¥260.79 Million
≈ $38.16 Million
0.340x -58.11%
2010-12-31 CN¥453.09 Million
≈ $66.30 Million
CN¥367.38 Million
≈ $53.76 Million
0.811x -70.23%
2009-12-31 CN¥135.17 Million
≈ $19.78 Million
CN¥368.21 Million
≈ $53.88 Million
2.724x +519.97%
2008-12-31 CN¥214.95 Million
≈ $31.45 Million
CN¥94.45 Million
≈ $13.82 Million
0.439x --

About Xizang Haisco Pharmaceutical Group Co Ltd

SHE:002653 China Biotechnology
Market Cap
$10.24 Billion
CN¥69.95 Billion CNY
Market Cap Rank
#2186 Global
#222 in China
Share Price
CN¥61.31
Change (1 day)
-6.34%
52-Week Range
CN¥42.93 - CN¥79.19
All Time High
CN¥79.19
About

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research c… Read more